Cargando…

Prevalence and Correlates of Caffeine Use Disorder Symptoms Among a United States Sample

Background: The DSM-5 recognizes caffeine use disorder as a condition for further study, but there is a need to better understand its prevalence and clinical significance among the general population. Methods: A survey was conducted among an online sample of 1006 caffeine-consuming adults using demo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sweeney, Mary M., Weaver, Darian C., Vincent, Kathryn B., Arria, Amelia M., Griffiths, Roland R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071067/
https://www.ncbi.nlm.nih.gov/pubmed/32181442
http://dx.doi.org/10.1089/caff.2019.0020
_version_ 1783506117586845696
author Sweeney, Mary M.
Weaver, Darian C.
Vincent, Kathryn B.
Arria, Amelia M.
Griffiths, Roland R.
author_facet Sweeney, Mary M.
Weaver, Darian C.
Vincent, Kathryn B.
Arria, Amelia M.
Griffiths, Roland R.
author_sort Sweeney, Mary M.
collection PubMed
description Background: The DSM-5 recognizes caffeine use disorder as a condition for further study, but there is a need to better understand its prevalence and clinical significance among the general population. Methods: A survey was conducted among an online sample of 1006 caffeine-consuming adults using demographic quotas to reflect the U.S. population. Caffeine consumption, DSM-proposed criteria for caffeine use disorder, sleep, substance use, and psychological distress were assessed. Results: Eight percent of the sample fulfilled DSM-proposed criteria for caffeine use disorder. These individuals consumed more caffeine, were younger, and were more likely to be cigarette smokers. Fulfilling caffeine use disorder criteria was associated with caffeine-related functional impairment, poorer sleep, some substance use, as well as greater depression, anxiety, and stress. Conclusions: The prevalence of caffeine use disorder among the present sample suggests that the proposed diagnostic criteria would identify only a modest percentage of the general population, and that identified individuals experience significant caffeine-related distress.
format Online
Article
Text
id pubmed-7071067
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Mary Ann Liebert, Inc., publishers
record_format MEDLINE/PubMed
spelling pubmed-70710672020-03-16 Prevalence and Correlates of Caffeine Use Disorder Symptoms Among a United States Sample Sweeney, Mary M. Weaver, Darian C. Vincent, Kathryn B. Arria, Amelia M. Griffiths, Roland R. J Caffeine Adenosine Res Original Articles Background: The DSM-5 recognizes caffeine use disorder as a condition for further study, but there is a need to better understand its prevalence and clinical significance among the general population. Methods: A survey was conducted among an online sample of 1006 caffeine-consuming adults using demographic quotas to reflect the U.S. population. Caffeine consumption, DSM-proposed criteria for caffeine use disorder, sleep, substance use, and psychological distress were assessed. Results: Eight percent of the sample fulfilled DSM-proposed criteria for caffeine use disorder. These individuals consumed more caffeine, were younger, and were more likely to be cigarette smokers. Fulfilling caffeine use disorder criteria was associated with caffeine-related functional impairment, poorer sleep, some substance use, as well as greater depression, anxiety, and stress. Conclusions: The prevalence of caffeine use disorder among the present sample suggests that the proposed diagnostic criteria would identify only a modest percentage of the general population, and that identified individuals experience significant caffeine-related distress. Mary Ann Liebert, Inc., publishers 2020-03-01 2020-03-04 /pmc/articles/PMC7071067/ /pubmed/32181442 http://dx.doi.org/10.1089/caff.2019.0020 Text en © Mary M. Sweeney, et al. 2020; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Sweeney, Mary M.
Weaver, Darian C.
Vincent, Kathryn B.
Arria, Amelia M.
Griffiths, Roland R.
Prevalence and Correlates of Caffeine Use Disorder Symptoms Among a United States Sample
title Prevalence and Correlates of Caffeine Use Disorder Symptoms Among a United States Sample
title_full Prevalence and Correlates of Caffeine Use Disorder Symptoms Among a United States Sample
title_fullStr Prevalence and Correlates of Caffeine Use Disorder Symptoms Among a United States Sample
title_full_unstemmed Prevalence and Correlates of Caffeine Use Disorder Symptoms Among a United States Sample
title_short Prevalence and Correlates of Caffeine Use Disorder Symptoms Among a United States Sample
title_sort prevalence and correlates of caffeine use disorder symptoms among a united states sample
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071067/
https://www.ncbi.nlm.nih.gov/pubmed/32181442
http://dx.doi.org/10.1089/caff.2019.0020
work_keys_str_mv AT sweeneymarym prevalenceandcorrelatesofcaffeineusedisordersymptomsamongaunitedstatessample
AT weaverdarianc prevalenceandcorrelatesofcaffeineusedisordersymptomsamongaunitedstatessample
AT vincentkathrynb prevalenceandcorrelatesofcaffeineusedisordersymptomsamongaunitedstatessample
AT arriaameliam prevalenceandcorrelatesofcaffeineusedisordersymptomsamongaunitedstatessample
AT griffithsrolandr prevalenceandcorrelatesofcaffeineusedisordersymptomsamongaunitedstatessample